What happened with CI today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
The Cigna Group helps employers and health insurers arrange prescription-drug benefits through Evernorth Health Services. Its Express Scripts business manages which drugs plans cover, negotiates prices and manufacturer rebates, and connects patients with retail pharmacies. Evernorth also fills prescriptions through home-delivery and specialty pharmacies. Payments for these prescriptions account for most of the group’s revenue; it also earns service fees, including fees from drug manufacturers. Express Scripts passes most manufacturer rebates back to clients rather than keeping them all, and some contracts require it to deliver a guaranteed rebate value.
Cigna Healthcare provides medical insurance and administers health plans. Most of its medical customers belong to employer-funded plans: employers pay the claims, while Cigna earns fees for claims administration and access to its provider network. Insured plans generate most of this division’s revenue through premiums. Cigna pays their medical claims and bears the cost when claims exceed premiums. Regulators restrict some premium changes, and minimum medical-spending requirements can oblige it to refund premiums.
The pharmacy business depends on prescription volume and the terms it negotiates with clients, pharmacies and drug suppliers. A single pharmacy-benefit client contributes a substantial share of group revenue, while one wholesaler supplies about half of Evernorth’s pharmaceutical purchases. The insurance business depends on setting premiums that cover medical costs, generally before the coverage period begins.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Cigna’s pharmacy-led results hinge on prescription volumes and contract terms, with privately held Prime Therapeutics and MedImpact also competing for pharmacy-benefit clients.
CVS Health competes with Cigna to manage clients’ prescription benefits and, through Aetna, to sell employers medical coverage or administer plans whose claims employers fund. Watch its pharmacy-benefit contract wins and Aetna’s employer business for signs of pressure on Cigna’s prescription volumes and plan-administration fees.
UnitedHealth Group’s Optum Rx competes with Cigna’s Express Scripts for contracts to manage clients’ prescription benefits. Optum Rx’s contract wins and losses are worth watching because client gains and losses affect Cigna’s pharmacy claim volume.
Centene pays Cigna’s Express Scripts to manage prescription benefits for its customers and provide access to a national retail-pharmacy network under a multiyear agreement that began January 1, 2024. Changes in Centene’s Medicaid, Medicare and commercial membership are worth watching for what they may mean for prescription volume handled by Cigna.
Elevance Health competes with Cigna for employers’ medical-insurance premiums and fees to administer employer-funded plans, while its CarelonRx business also overlaps with Evernorth’s pharmacy services. Watch Elevance’s business with very large multistate employers, where it says its Blue Cross and Blue Shield brand helps it compete.
The Cigna Group earningsThis company
Cigna Group earns most of its revenue through Evernorth’s pharmacy-benefit and related services; this report will show whether more prescription volume is adding operating income or being eaten up by client pricing and service costs.
Read Evernorth’s adjusted pharmacy scripts alongside its pre-tax adjusted operating margin. More scripts with a steadier margin would show that added business is still producing profit; more scripts with a further margin decline would show that the cost of winning clients and serving more volume is eating into the return on each unit of business. Together, the figures show whether Cigna Group’s growth is earning its keep.
